IFF Pharma Solutions
IFF offers a vast portfolio of differentiated ingredient solutions for customers of all sizes, across the food, beverage, health, biosciences and sensorial experiences industries. Its IFF Pharma Solutions division, which was formed when IFF merged with DuPont’s Nutrition & Biosciences division in 2021, provides a broad and unique range of well-known excipients for oral solid dosage forms.
DuPont Nutrition & Biosciences business was itself formed from various mergers, spinouts and asset swaps during the 2010s involving DuPont, FMC and Dow and now has one of the industry’s broadest and most flexible portfolios of oral solid dosage advanced pharmaceutical ingredients and excipients. It offers solutions for tablets, capsules, multiparticulates and suspensions including: immediate, delayed, and sustained release systems; taste masking; enhanced bioavailability for novel advanced pharmaceutical ingredients; and naturally derived vegetarian capsules.